Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Bemærk venligst, at rapporten udelukkende forefindes på engelsk. Revenue up 7%, full-year outlook maintained (unaudited) ALK’s overall results in Q1 2023 were largely as expected, with 7% organic...
-
Revenue up 7%, full-year outlook maintained (unaudited) ALK’s overall results in Q1 2023 were largely as expected, with 7% organic revenue growth in local currencies and increased operating profit...
-
MindMed Board has Presided over Botched Regulatory Strategies, Outsized Expenses, Soaring Executive Compensation, and Value Destructive Financings FCM’s Four Highly Qualified Director Nominees to...
-
PUNE, May 05, 2023 (GLOBE NEWSWIRE) -- "Dentures Market" research report focus on overall information that can help to take decisions on current market situation. Dentures Market Report...
-
PUNE, May 04, 2023 (GLOBE NEWSWIRE) -- "Fulfillment Services Market" research report focus on overall information that can help to take decisions on current market situation. Fulfillment Services...
-
PUNE, May 04, 2023 (GLOBE NEWSWIRE) -- "Hair Removal Device Market" research report focus on overall information that can help to take decisions on current market situation. Hair Removal Device...
-
First Quarter 2023 ResultsAll amounts expressed in US dollars TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) — The completion of major processing plant...
-
Aðalfundur Ölgerðarinnar Egill Skallagrímsson hf., kt. 420369-7789, verður haldinn fimmtudaginn 25. maí 2023, kl. 16:00, í höfuðstöðvum félagsins að Grjóthálsi 7-11 í Reykjavík. Fundarboð með drögum...
-
Live-Webcast am Dienstag, den 2. Mai, um 14:30 Uhr MESZ Update umfasst Daten von 11 stark vorbehandelten Patienten nach Letztlinientherapie in der Phase-1b-Dosisexpansionskohorte A, die mit der...
-
Company to host conference call today, May 2, at 8:30 am EDT / 2:30 pm CEST Update covers data from 11 heavily pre-treated, last-line patients in Phase 1b dose expansion Cohort A treated with IMA203...